Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
4
×
clinical trials
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
celgene
detroit blog main
detroit top stories
drugs
eli lilly
fda
genentech
gilead sciences
indiana blog main
indiana top stories
intercept pharmaceuticals
johnson & johnson
national
nonalcoholic steatohepatitis
obeticholic acid
raleigh-durham blog main
raleigh-durham top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
What
known
4
×
disease
approved
bio
drug
fatty
liver
nash
new
roundup
biopharma
cancer
cancer’s
companies
congress
congressional
crispr
data
digital
epidemic
executives
fda
feud
frenzied
frontiers
group
growing
horizon
intercept
ipo
isn’t
later
led
maps
marketed
medicine
medicines
merck
month
news
Language
unset
Current search:
known
×
photo
×
" boston top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
